 |
|
|
| |
HIV-1 REPLICATION AT <50 C/ML TO 148 WEEKS FOR SWORD
1 TO 148 WEEKS FOR SWORD-1/SWORD-2 Studies with DTG+RPV
|
| |
| |
CROI 2020 March 8-11
Reported by Jules Levin
Mark Underwood1, Kostas Angelis2, Ruolan Wang1, Joe Horton3, Veerle Van Eygen4, Jessica
Matthews1, Lesley Kahl5, Jean van Wyk5, Brian Wynne1
1ViiV Healthcare, Research Triangle Park, NC, USA,2GlaxoSmithKline, Uxbridge, UK,3PAREXEL International, Durham, NC, USA,4Janssen, Beerse, Belgium,5ViiV Healthcare, Brentford, UK
|
| |
|
|
|
|
|
